Align Financial’s Idexx Laboratories IDXX Stock Holding History

Align Financial’s Portfolio IDXX Stock Details IDXX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$522	Buy	+1	New	+$548	﹤0.01%	477

Other funds holding IDXX

Montrusco Bolton Investments Montreal, Quebec, Canada $5.77B AUM 24.61% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return

Congress Asset Management Boston, Massachusetts $15.4B AUM 30.35% 1-Year Est. Return

Vontobel Holding Zurich, Switzerland $27.7B AUM 21.75% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

Seilern Investment Management London, United Kingdom $771M AUM 2.59% 1-Year Est. Return

Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.31B AUM 25.55% 1-Year Est. Return

Mogy Joel R Investment Counsel Beverly Hills, California $1.87B AUM 18.64% 1-Year Est. Return

Manitou Investment Management Toronto, Ontario, Canada $532M AUM 7.98% 1-Year Est. Return

Chicago Capital Chicago, Illinois $4.32B AUM 31.14% 1-Year Est. Return

Align Financial's IDXX Position: Q3 2026 in Review

Align Financial opened a new position in Idexx Laboratories (IDXX) in Q3 2026: 1 share worth $522. The stake represents ﹤0.01% of the portfolio and ranks #477 among its holdings.

224 funds tracked by Wall St. Rank hold IDXX as of Q3 2026.

Align Financial held 1 share of Idexx Laboratories worth $522 as of Q3 2026.
Idexx Laboratories was a new Align Financial position in Q3 2026.
Idexx Laboratories made up ﹤0.01% of Align Financial's portfolio in Q3 2026, its #477 holding.
224 funds tracked by Wall St. Rank held Idexx Laboratories as of Q3 2026.

Based on Align Financial's 13F filing for Q3 2026, filed 16 Oct 2026.